Clinical Trials

NCT07271368 | RECRUITING | NA

25 participants

EXTERNAL NEGATIVE PRESSURE DURING LISA

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-03-17

Completion:

2027-03-30

Conditions

• Neonatology

Interventions

• PROCEDURE

No Results Yet

NCT07271355 | NOT_YET_RECRUITING | PHASE3

129 participants

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-10-01

Completion:

2031-02-28

Conditions

• Metastatic Appendix Carcinoma
• Metastatic Colorectal Carcinoma
• Metastatic Malignant Neoplasm in the Peritoneum
• Stage IV Appendix Carcinoma AJCC v8
• Stage IVC Colorectal Cancer AJCC v8
• Unresectable Colorectal Carcinoma

Interventions

• BIOLOGICAL
• PROCEDURE
• DRUG
• OTHER

No Results Yet

NCT07270614 | COMPLETED | NA

37 participants

Eight-week Sports Injury Prevention Program

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-02-16

Completion:

2025-11-30

Conditions

• Health Adult Subjects

Interventions

• BEHAVIORAL

No Results Yet

NCT07269730 | COMPLETED | NA

15 participants

Effects of Calcium-Containing Oral Sprays on Fluorescence-Detectable Plaque Area in Children

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2023-06-11

Completion:

2024-08-05

Conditions

• Dental Caries Tooth Demineralization
• Early Childhood Caries (ECC)

Interventions

• OTHER

No Results Yet

NCT07267364 | RECRUITING | NA

48 participants

Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-11-11

Completion:

2026-02-01

Conditions

• Urology
• Pediatric Disorder

Interventions

• BEHAVIORAL

No Results Yet

NCT07265947 | RECRUITING | PHASE2

230 participants

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-12-22

Completion:

2030-10-31

Conditions

• Low Grade Upper Tract Urothelial Carcinoma

Interventions

• DRUG

No Results Yet

NCT07265180 | RECRUITING | NA

120 participants

Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-09-08

Completion:

2026-11-30

Conditions

• Schizophrenia Spectrum Disorders (SSD)

Interventions

• OTHER

No Results Yet

NCT07261241 | NOT_YET_RECRUITING | PHASE2

118 participants

NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-12-31

Completion:

2030-12-31

Conditions

• Neuroblastoma

Interventions

• DRUG

No Results Yet

NCT07240077 | RECRUITING | PHASE4

165 participants

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-01-08

Completion:

2027-12-31

Conditions

• Bacteremia
• Streptococcus Infection

Interventions

• DRUG

No Results Yet

NCT07227597 | RECRUITING | PHASE1/PHASE2

170 participants

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-01-29

Completion:

2030-11-29

Conditions

• Small Cell Lung Cancer Extensive Stage

Interventions

• DRUG

No Results Yet

NCT07226128 | RECRUITING | NA

150 participants

The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-04-10

Completion:

2029-08-31

Conditions

• HIV
• Depression in Adults
• Insulin Resistance
• Cognitive Behavior Therapy

Interventions

• BEHAVIORAL

No Results Yet

NCT07225855 | RECRUITING | NA

36 participants

Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family Caregivers

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-10-01

Completion:

2027-11-24

Conditions

• Localized Head and Neck Carcinoma

Interventions

• OTHER
• BEHAVIORAL

No Results Yet

NCT07223840 | RECRUITING | PHASE2

222 participants

A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-11-03

Completion:

2027-02-28

Conditions

• Smoking

Interventions

• DRUG

No Results Yet

NCT07223593 | RECRUITING | PHASE3

1205 participants

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-31

Completion:

2028-06-30

Conditions

• Peripheral Arterial Disease

Interventions

• DRUG

No Results Yet

NCT07221617 | RECRUITING | PHASE4

100 participants

Oral Methadone in Cardiac Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-01-13

Completion:

2026-08-31

Conditions

• Pain, Postoperative
• Anesthesia
• Cardiac Surgery

Interventions

• DRUG

No Results Yet

NCT07221474 | RECRUITING | PHASE2

180 participants

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-12-12

Completion:

2029-07-02

Conditions

• Squamous Non-small Cell Lung Cancer

Interventions

• BIOLOGICAL
• DRUG
• OTHER

No Results Yet

NCT07221253 | RECRUITING | PHASE3

1100 participants

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-12-04

Completion:

2029-07-31

Conditions

• Biliary Tract Cancer

Interventions

• DRUG

No Results Yet

NCT07220252 | RECRUITING | PHASE2/PHASE3

240 participants

Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-07-01

Completion:

2030-01-01

Conditions

• Relapsing Multiple Sclerosis

Interventions

• DRUG

No Results Yet

NCT07219953 | RECRUITING | PHASE3

1100 participants

A Study of Brenipatide in Participants With Alcohol Use Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-16

Completion:

2028-04-30

Conditions

• Alcohol Use Disorder

Interventions

• DRUG

No Results Yet

NCT07219173 | RECRUITING | PHASE2

531 participants

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-22

Completion:

2028-04-30

Conditions

• Asthma

Interventions

• DRUG

No Results Yet

NCT07218380 | RECRUITING | PHASE3

450 participants

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-12-12

Completion:

2029-10-31

Conditions

• Carcinoma, Transitional Cell
• Urinary Bladder Neoplasms
• Neoplasm Metastasis

Interventions

• DRUG
• OTHER

No Results Yet

NCT07216560 | RECRUITING | PHASE1/PHASE2

200 participants

First-in-human Study of 7MW4911 in GI Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-01-13

Completion:

2027-07-31

Conditions

• GI Cancers

Interventions

• DRUG

No Results Yet

NCT07215559 | RECRUITING | PHASE2

200 participants

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-16

Completion:

2027-03-31

Conditions

• Obesity
• Overweight
• Diabetes Mellitus, Type 2

Interventions

• DRUG

No Results Yet

NCT07215078 | COMPLETED | PHASE1

72 participants

Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-08

Completion:

2026-07-21

Conditions

• Healthy Volunteer

Interventions

• DRUG

No Results Yet

NCT07214662 | TERMINATED | PHASE1

3 participants

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-01-13

Completion:

2026-06-24

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT07213986 | RECRUITING | NA

12 participants

Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-01-06

Completion:

2026-08-19

Conditions

• Neurogenic Bowel Dysfunction
• Spinal Cord Injury

Interventions

• DEVICE

No Results Yet

NCT07213804 | RECRUITING | PHASE3

1630 participants

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-22

Completion:

2028-11-30

Conditions

• Ovarian Neoplasms
• Fallopian Tube Neoplasms
• Peritoneal Neoplasms
• Neoplasm Metastasis

Interventions

• DRUG

No Results Yet

NCT07213635 | ACTIVE_NOT_RECRUITING | PHASE4

56 participants

Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-20

Completion:

2026-08-12

Conditions

• Opioid Use
• Surgical Recovery
• Vaginal Hysterectomy
• Prolapse Pelvic
• Postoperative Pain

Interventions

• DRUG

No Results Yet

NCT07211633 | ACTIVE_NOT_RECRUITING | PHASE3

360 participants

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-07-09

Completion:

2026-10-31

Conditions

• Relapsing Multiple Sclerosis

Interventions

• BIOLOGICAL

No Results Yet

NCT07211438 | RECRUITING | PHASE2

40 participants

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-07-03

Completion:

2028-07-31

Conditions

• Treatment-Resistant Depression

Interventions

• DRUG

No Results Yet

NCT07209241 | ACTIVE_NOT_RECRUITING | PHASE1

12 participants

Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-12-03

Completion:

2042-11-01

Conditions

• Recurrent Glioblastoma

Interventions

• BIOLOGICAL

No Results Yet

NCT07209111 | RECRUITING | PHASE2

150 participants

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-12-04

Completion:

2032-04-09

Conditions

• Neoplasm Malignant

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT07206056 | RECRUITING | PHASE1/PHASE2

188 participants

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-15

Completion:

2029-11-09

Conditions

• Progressive Metastatic Castrate Resistant Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT07192471 | RECRUITING | PHASE1

72 participants

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2026-09-30

Completion:

2029-03-31

Conditions

• T-cell NHL (PTCL or CTCL)

Interventions

• DRUG

No Results Yet

NCT07191067 | RECRUITING | NA

120 participants

Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-09-30

Completion:

2026-12-31

Conditions

• Pain

Interventions

• DEVICE

No Results Yet

NCT07188623 | RECRUITING | NA

30 participants

Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-09-30

Completion:

2026-12-31

Conditions

• Depression - Major Depressive Disorder
• Older Adults (65 Years and Older)
• Behavioral Activation Treatment
• Virtual Reality Therapy

Interventions

• BEHAVIORAL

No Results Yet

NCT07188376 | RECRUITING | NA

12 participants

Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-10-30

Completion:

2027-06-01

Conditions

• Alcohol Risk Behaviors

Interventions

• DEVICE

No Results Yet

NCT07186101 | RECRUITING | PHASE2

252 participants

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-11-10

Completion:

2027-05-31

Conditions

• Ulcerative Colitis

Interventions

• DRUG

No Results Yet

NCT07177352 | RECRUITING | PHASE3

80000 participants

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-07-02

Completion:

2035-07-31

Conditions

• Alzheimers Disease

Interventions

• OTHER

No Results Yet

NCT07174336 | RECRUITING | PHASE3

800 participants

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-21

Start Date:

2025-12-22

Completion:

2029-05-31

Conditions

• Breast Neoplasms
• Neoplasm Metastasis

Interventions

• DRUG

No Results Yet